Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
164 participants
INTERVENTIONAL
2015-03-31
2021-11-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Clear Aligner Trays to Straighten Teeth
NCT03141788
Invisalign® System with Mandibular Advancement
NCT06651944
Comparison of Skeletal Effects of Herbst and Invisalign MA in Growing Patients With KLass II Malocclusion
NCT06409923
Comparison Between 2 Protocols for the Treatment of Class II Division 2 Malocclusion
NCT03833739
Early Treatment for Class II Division 1 Malocclusion With Twicare® and Herbst Removable Appliances
NCT02428621
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The Invisalign System
Class II correction of malocclusions
Invisalign System
The Invisalign® System is indicated for the alignment of teeth during orthodontic treatment of malocclusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Invisalign System
The Invisalign® System is indicated for the alignment of teeth during orthodontic treatment of malocclusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age range 11-19 years old
* Subject that requires bilateral Class II correction and must require at least 3mm of correction as measured by first molar relationship
Exclusion Criteria
* Subject who has spaces between adjacent teeth larger than 3mm
* Subject with active caries
* Subject with periodontal disease
* Subject does not have at least 1st molar fully captured in PVS (polyvinyl siloxane material ) impression or intraoral scan.
* Subject with TMD (Temporomandibular joint dysfunction) symptoms
* Subject has undergone pre-treatment with any orthodontic appliance (any previous treatment prior to study)
* Subject has known allergy to latex and plastic
* Subjects who are pregnant or will become pregnant during treatment
11 Years
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Align Technology, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sherri Wilson-Lopes
Role: STUDY_DIRECTOR
Align Technology, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Gary Brigham
Scottsdale, Arizona, United States
Dr. Donna Galante
Rocklin, California, United States
Dr. Mark Holt
Roseville, California, United States
Dr. Ray Kubisch and Dr. Drew Ferris
Santa Barbara, California, United States
Dr. Sandra Selnick
Ellicott City, Maryland, United States
Dr. Regina Blevins
Inver Grove Heights, Minnesota, United States
Dr. William Kottemann
Maple Grove, Minnesota, United States
Dr. Barry Glaser
Cortlandt Manor, New York, United States
Dr. Sam Daher
Vancouver, British Columbia, Canada
Dr. Sandra Tai
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MRF-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.